#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fibrodysplasia ossificans progressiva HER2 mutant non-small cell lung cancer Cervix carcinoma Squamous cell carcinoma of the hypopharynx Acquired C1 inhibitor deficiency Adrenogenital syndrome Obliterative bronchiolitis Exudative retinopathy Urethral valves Desmoid tumour Alveolar proteinosis Andersen-Tawil syndrome Systemic candida Neuronal ceroid lipofuscinosis Hypersensitivity pneumonitis More trials…

    Learn about Rare Diseases

    X-linked lymphoproliferative syndrome – Trials in Disease Hepatic angiosarcoma – Diagnostics Behcet’s syndrome – Basic Information Proteus syndrome – Diagnostics Behcet’s syndrome – Treatment Friedreich’s ataxia – Life with Disease Congenital hypotransferrinaemia – Diagnostics Phenylketonuria – Life with Disease Leiomyosarcoma metastatic – Treatment Hairy cell leukaemia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clindamycin Vafidemstat Metoprolol Epoetin Alfa Cft1946 Zinc Acexamate Formoterol Fumarate Dihydrate Colistin Sulfate Anhydrous Benzoyl Peroxide Satralizumab Lacosamide H2-Receptor Antagonist Regn7257 Metformin Embonate ULTEVURSEN Avapritinib Rbl012.2 Sodium S-Lactate Solution Lifileucel MAGNESIUM ACETATE TETRAHYDRATE More therapies…

    Learn about Your Condition

    Hepatorenal syndrome Skin ulcer Cachexia Renal failure Essential hypertension Ulcerative keratitis Langerhans' cell histiocytosis Asthmatic crisis Endocarditis enterococcal Toxic epidermal necrolysis Abortion threatened Haemofiltration Rhinitis allergic Uterine cancer Alcoholic liver disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study on the Safety and Effectiveness of Clesrovimab and Palivizumab for Preventing Severe RSV in Infants and Children at High Risk

    Not recruiting

    3 1 1
    Investigated Drugs:
    • CLESROVIMAB
    • Palivizumab
    • Sodium Chloride
    Czechia Finland France Germany Greece Hungary +3

  • Study Comparing Intradermal and Intramuscular Rabies Vaccine Doses in Adults

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rabies
    Belgium

  • Study on 2-Deoxy-D-Glucose for Preventing Common Cold in Healthy Adults

    Not recruiting

    2 1
    Investigated Drugs:
    • 2-DEOXY-D-GLUCOSE
    The Netherlands

  • Study on the Immune Response of COVID-19 Vaccine Tozinameran with Flu Vaccine Combinations in Adults Aged 65 and Over

    Not recruiting

    2 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • A/DARWIN/9/2021 (H3N2) – LIKE STRAIN (A/DARWIN/6/2021, IVR-227)
    • Tozinameran
    • A/Victoria/4897/2022 (H1N1)Pdm09-Like Strain (A/Victoria/4897/2022, Ivr-238)
    Belgium The Netherlands

  • Study on the Effects of Tobevibart and Elebsiran Compared to Bulevirtide for Patients with Chronic Hepatitis D Virus Infection

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatitis B
    • Hepatitis D
    Investigated Drugs:
    • Bulevirtide
    • Elebsiran
    • Tobevibart
    Belgium Bulgaria France Germany Italy The Netherlands +2

  • Study on Long-Term Effects and Safety of Herpes Zoster Vaccine with Recombinant Varicella Zoster Virus Glycoprotein E in Older Adults

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Recombinant Varicella Zoster Virus Glycoprotein E
    Czechia Estonia Finland France Germany Italy +2
Previous Page
1 … 30 31 32 33 34 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!